Fenske Sara A, Yesilaltay Ayce, Pal Rinku, Daniels Kathleen, Barker Caroline, Quiñones Verónica, Rigotti Attilio, Krieger Monty, Kocher Olivier
Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
J Biol Chem. 2009 Feb 27;284(9):5797-806. doi: 10.1074/jbc.M808211200. Epub 2008 Dec 30.
PDZK1 is a four PDZ domain-containing scaffold protein that binds to scavenger receptor class B, type I (SR-BI), the high density lipoprotein receptor, by its first PDZ domain (PDZ1). PDZK1 knock-out mice exhibit a >95% decrease in hepatic SR-BI protein and consequently an approximately 70% increase in plasma cholesterol in abnormally large high density lipoprotein particles. These defects are corrected by hepatic overexpression of full-length PDZK1 but not the PDZ1 domain alone, which partially restores SR-BI protein abundance but not cell surface expression or function. We have generated PDZK1 knock-out mice with hepatic expression of four PDZK1 transgenes encoding proteins with nested C-terminal truncations: pTEM, which lacks the three C-terminal residues (putative PDZ-binding motif), and PDZ1.2, PDZ1.2.3, or PDZ1.2.3.4, which contain only the first two, three, or four N-terminal PDZ domains, respectively, but not the remaining C-terminal sequences. Hepatic overexpression of pTEM restored normal hepatic SR-BI abundance, localization, and function. Hepatic overexpression of PDZ1.2 or PDZ1.2.3 partially restored SR-BI abundance ( approximately 12 or approximately 30% of wild type, respectively) but did not (PDZ1.2) or only slightly (PDZ1.2.3) restored hepatic SR-BI cell surface localization and function. Hepatic overexpression of PDZ1.2.3.4 completely restored SR-BI protein abundance, cell surface expression, and function (normalization of plasma cholesterol levels). Thus, all four PDZ domains in PDZK1, but not PDZ1-3 alone, are sufficient for its normal control of the abundance, localization, and therefore function of hepatic SR-BI, whereas the residues C-terminal to the PDZ4 domain, including the C-terminal putative PDZ-binding domain, are not required.
PDZK1是一种含有四个PDZ结构域的支架蛋白,它通过其第一个PDZ结构域(PDZ1)与B类清道夫受体I型(SR-BI,即高密度脂蛋白受体)结合。PDZK1基因敲除小鼠肝脏中SR-BI蛋白减少超过95%,因此异常大的高密度脂蛋白颗粒中的血浆胆固醇升高约70%。这些缺陷可通过全长PDZK1在肝脏中的过表达得到纠正,但单独的PDZ1结构域则不能,它只能部分恢复SR-BI蛋白丰度,而不能恢复细胞表面表达或功能。我们构建了PDZK1基因敲除小鼠,并使其肝脏表达四个编码具有嵌套C端截短的蛋白质的PDZK1转基因:pTEM,它缺少三个C端残基(假定的PDZ结合基序),以及PDZ1.2、PDZ1.2.3或PDZ1.2.3.4,它们分别仅包含前两个、三个或四个N端PDZ结构域,而不包含其余的C端序列。pTEM在肝脏中的过表达恢复了肝脏中正常的SR-BI丰度、定位和功能。PDZ1.2或PDZ1.2.3在肝脏中的过表达部分恢复了SR-BI丰度(分别约为野生型的12%或约30%),但没有(PDZ1.2)或仅轻微(PDZ1.2.3)恢复肝脏SR-BI的细胞表面定位和功能。PDZ1.2.3.4在肝脏中的过表达完全恢复了SR-BI蛋白丰度、细胞表面表达和功能(血浆胆固醇水平正常化)。因此,PDZK1中的所有四个PDZ结构域,而不是单独的PDZ1-3,足以对肝脏SR-BI的丰度、定位以及功能进行正常调控, 而PDZ4结构域C端的残基,包括C端假定的PDZ结合结构域,则不是必需的。